SCHEMBL370659

SCHEMBL370659

Cc1cccc(Nc2nc(-c3c[nH]nc3C)cs2)n1.Cc1sc(Nc2ccc(F)cn2)nc1-c1cn[nH]c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 7/20 0.51
NPC1 O15118 11/20 0.47
RAB9A P51151 11/20 0.47
MEN1 O00255 10/20 0.47
KMT2A Q03164 10/20 0.47
GRM8 O00222 1/20 0.45
KCNH2 Q12809 1/20 0.44
ATM Q13315 2/20 0.41
CASP3 P42574 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
POLB P06746 3/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 3/20 0.39
NFKB1 P19838 3/20 0.39
NFKB2 Q00653 3/20 0.39
RELA Q04206 3/20 0.39
ALDH1A1 P00352 2/20 0.39
TP53 P04637 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL370801 0.80 GRM4 (0.69) GRM4NPC1RAB9AGRM8KCNH2
SCHEMBL370608 0.78 NPC1 (0.61) GRM4NPC1RAB9AMEN1KMT2A
SCHEMBL369427 0.78 GRM4 (0.72) GRM4NPC1RAB9AMEN1KMT2A
SCHEMBL369610 0.75 GRM4 (0.56) GRM4NPC1RAB9AMEN1KMT2A
SCHEMBL369379 0.75 GRM4 (0.82) GRM4NPC1RAB9AMEN1KMT2A
SCHEMBL369856 0.74 GRM4 (0.55) GRM4NPC1RAB9AMEN1KMT2A
SCHEMBL365863 0.74 NPC1 (0.68) GRM4NPC1RAB9AMEN1KMT2A
SCHEMBL12482359 0.73 GRM4 (0.47) GRM4NPC1RAB9AMEN1KMT2A
SCHEMBL370821 0.72 GRM4 (0.57) GRM4NPC1RAB9AMEN1KMT2A
SCHEMBL369775 0.72 GRM4 (0.69) GRM4RAB9AMEN1KMT2AGRM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2595986-A2 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS Addex Pharma SA (CH) 2013-05-29 EP claimed
WO-2012009009-A2 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMA S.A. (CH) 2012-01-19 WO claimed
US-20110257179-A1 NOVEL THIAZOLES DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMA SA (CH) 2011-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257179-A1 NOVEL THIAZOLES DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS GRM4, GRM2, GRM1 GRM4 1/4885NPC1 1128/4885RAB9A 2177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.